| Literature DB >> 18258032 |
Inge van Loo1, Xander Huijsdens, Edine Tiemersma, Albert de Neeling, Nienke van de Sande-Bruinsma, Desiree Beaujean, Andreas Voss, Jan Kluytmans.
Abstract
In 2003 in the Netherlands, a new methicillin-resistant Staphylococcus aureus (MRSA) strain emerged that could not be typed with Sma1 pulsed-field gel electrophoresis (NT-MRSA). The association of NT-MRSA in humans with a reservoir in animals was investigated. The frequency of NT-MRSA increased from 0% in 2002 to >21% after intensified surveillance was implemented in July 2006. Geographically, NT-MRSA clustered with pig farming. A case-control study showed that carriers of NT-MRSA were more often pig or cattle farmers (pig farmers odds ratio [OR] 12.2, 95% confidence interval [CI] 3.1-48.6; cattle farmers OR 19.7, 95% CI 2.3-169.5). Molecular typing showed that the NT-MRSA strains belonged to a new clonal complex, ST 398. This study shows that MRSA from an animal reservoir has recently entered the human population and is now responsible for >20% of all MRSA in the Netherlands.Entities:
Mesh:
Year: 2007 PMID: 18258032 PMCID: PMC2876750 DOI: 10.3201/eid1312.070384
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Figure 1A) Number of nontypable methicillin-resistant Staphylococcus aureus (NT-MRSA) isolates per municipality received at the National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands, January 2003–June 2005. The background color represents the density of pigs per km2 in 2003. B) Number of typable MRSA per municipality received at the RIVM January 2003–June 2005. The background color represents the population density per km2 (source: CBS Statline).
Results of univariate analysis of case-control study, the Netherlands, February 2007*
| Variable | Cases | Controls | Odds ratio (95% CI)† | p value | |||
|---|---|---|---|---|---|---|---|
| No. | No. (%) or mean ± SD with variable | No. | No. (%) or mean ± SD with variable | ||||
| Gender (male) | 35 | 20 (57) | 76 | 36 (47) | 1.5 (0.7–3.3) | 0.34 | |
| Age, y | 35 | 42.7 ± 25.3 | 76 | 47.3 ± 24.7 | 0.37 | ||
| Residence | 35 | 75 | |||||
| Rural area | 14 (40) | 6 (8) | 7.7 (2.6–22.7)§ | <0.01 | |||
| Urban area | 20 (57) | 66 (85) | |||||
| Foreign country |
| 1 (3) |
|
| 3 (4) |
|
|
| Contact with pigs | 29 | 11 (38) | 63 | 3 (5) | 12.2 (3.1–48.6) | <0.01 | |
| Contact with cattle | 29 | 7 (24) | 63 | 1 (2) | 19.7 (2.3–169.5) | <0.01 | |
| Unexpected MRSA | 35 | 27 (77) |
| 76 | 34 (45) | 4.2 (1.7–10.4) | <0.01 |
| Probable source | 35 | 76 | |||||
| Healthcare | 5 (14) | 39 (51) | 0.01 | ||||
| Foreign country | 3 (9) | 5 (7) | |||||
| Other | 12 (34) | 10 (13) | |||||
| Unknown |
| 15 (43) |
|
| 22 (29) |
|
|
| Active infection | 35 | 19 (54) | 76 | 29 (38) | 1.9 (0.9–4.3) | 0.11 | |
| Skin/soft tissue | 10 (56) | 24 (83) | 0.3 (0.1–1.0) | 0.05 | |||
| Airways | 3 (17) | 0 | |||||
| Other | 6 (28) | 5 (17) | |||||
| Hospital admission | 35 | 17 (49) | 76 | 24 (32) | 2.0 (0.9–4.6) | 0.08 | |
| Hospital stay, d | 16 | 18.9 ± 20.2 | 22 | 23.5 ± 30.9 | 0.60 | ||
*SD, standard deviation; CI, confidence interval; No., number of cases or controls for whom data are available. †Odds ratio was determined for rural area relative to urban area.
Figure 2Genetic relatedness of methicillin-resistant Staphylococcus aureus from cases and controls, represented as a minimum spanning tree based on multilocus sequence typing (MLST) profiles. Each circle represents a sequence type, and numbers in the circles denote the sequence type. The size of the circle indicates the number of isolates with this sequence type. The number under and right of the lines connecting types denotes the number of differences in MLST profiles. The halos surrounding the circles indicate complexes of sequence types that differ by <3 loci.
Typing results for cases and the number of controls with the same type, the Netherlands, February 2007
| Type | Cases, no. (%) | Controls, no. (%) | p value |
|---|---|---|---|
|
| |||
| t108 | 14 (40) | 0 | <0.01 |
| t011 | 8 (23) | 0 | |
| t034 | 6 (17) | 0 | |
| t571 | 3 (9) | 0 | |
| t567 | 2 (6) | 0 | |
| t337 | 1 (3) | 0 | |
| t898 | 1 (3) | 0 |
|
| SCC | |||
| I | 0 | 4 (9) | <0.01 |
| II | 0 | 7 (16) | |
| III | 4 (17) | 6 (14) | |
| IV | 2 (8) | 21 (49) | |
| V | 18 (75) | 5 (12) |
Panton-Valentine leukocidin
3 (9)
10 (14)
0.21
Number and percentage of resistant MRSA isolates for various antimicrobial agents, the Netherlands, February 2007*
| Agent | Cases, no. (%) | Controls, no. (%) | p value |
|---|---|---|---|
| Doxycycline | 25 (78) | 10 (14) | <0.01 |
| Ciprofloxacin | 1 (3) | 36 (49) | <0.01 |
| Tobramycin | 4 (13) | 25 (34) | 0.02 |
| Gentamicin | 2 (6) | 12(16) | 0.14 |
| Clindamycin | 12 (38) | 15 (20) | 0.05 |
| Erythromycin | 15 (46) | 29 (39) | 0.35 |
| Cotrimoxazole | 0 | 7 (10) | 0.07 |
| Rifampin | 0 | 6 (8) | 0.11 |
| Mupirocin | 0 | 5 (7) | 0.15 |
| Vancomycin | 0 | 0 |
*MRSA, methicillin-resistant Staphylococcus aureus.